In what may be the largest and fastest operation ever carried out in the world, UNICEF has announced that it will lead the procurement and supply of coronavirus vaccines to ensure that all countries have safe, timely and equitable access to the initial doses when available.
The United Nations Children’s Fund is the world’s largest buyer of vaccines and buys more than 2 billion doses of vaccines a year for immunization of regimens and reaction to outbreaks on behalf of some 100 countries.
With several promising candidate vaccines, the United Nations agency, in collaboration with the Pan American Health Organization’s Renewable Fund, will lead efforts to acquire and distribute doses of COVID-19 vaccines on behalf of the COVAX Global Vaccine Center for low and low levels. -Countries of income, the vaccine of which it acquires will be supported through the mechanism.
UNICEF will also serve as purchasing coordinator for purchases in 80 higher-income economies, which have expressed their goal of participating in the COVAX mechanism and will fund vaccines on their own budgets, he said.
The vaccine procurement and distribution effort, which involves more than 170 savings, has the prospect of the largest and fastest operation of its kind in the world.
“This is a full-grade partnership between governments, brands and multilateral partners to continue the high-risk fight against the COVID-19 pandemic,” said UNICEF Executive Director Henrietta Fore. Approximately 28 brands have shared their annual COVID-19 vaccine production plans with UNICEF, which said in a market assessment that drug manufacturers were ready to jointly produce “unprecedented amounts” of vaccines over the years. Next 1 to 2 years.
However, the brands reported that investments in dosing production on such a scale would largely count, inter alia, the good fortunes of clinical trials, early procurement agreements were established, funding was demonstrated, and regulatory and registration pathways were simplified.
Sputnik trials in India:
Clinical trials of the Russian vaccine opposed to Sputnik V will begin this month in Saudi Arabia, the United Arab Emirates, the Philippines, India and Brazil, and the preliminary effects of the Phase III trial will be published in October-November.
Chinese vaccines on display:
China has first exposed its vaccines opposed to local coronaviruses, as the country where the contagion was discovered seeks to shape the narrative surrounding the pandemic. Chinese companies Sinovac Biotech and Sinopharm.
Neither has yet entered the market, but the brands expect to be approved after the gigantic Phase 3 tests by the end of the year. A Sinovac representative told the AFP that his company had already “completed the structure of a vaccine plant. “”, which will consist of producing three hundred million doses according to the year.
China’s nationalist tabloid Global Times reported last month that “the value of vaccines will be high. “Both doses are expected to charge less than 1,000 yuan ($146), the report says, which mentions the president of Sinopharm, who told the media that he had already won an injection of one of the candidate vaccines.
Chinese state news firm Xinhua reported Monday that the candidate vaccine, developed through Chinese army scientists, could possibly cope with mutations in the coronavirus.